COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

CPAP May Offer Enhanced BP Benefit in Sleep Apnea & Insomnia

Patients with both insomnia and obstructive sleep apnea may represent a clinical phenotype characterized by an enhanced systolic BP-lowering response to continuous positive airway pressure therapy.

Australia Confirms First H5N1 Bird Flu Case in Local Mammal

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC
HTTP error: 503HTTP error: 503

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Latest News

Patients with both insomnia and obstructive sleep apnea may represent a clinical phenotype characterized by an enhanced systolic BP-lowering response to continuous positive airway pressure therapy.
HTTP error: 503HTTP error: 503

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC
HTTP error: 503HTTP error: 503

News All Time

HTTP error: 503HTTP error: 503HTTP error: 503

Tenax Heart Drug Fails to Improve Walking Results in Study, Shares Plunge

Tenax Therapeutics said on Monday its experimental drug did not significantly improve how far patients could walk compared with ⁠placebo in a late-stage trial for a...

Ivacaftor Boosts Height and Lung Function in Cystic Fibrosis

Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have improved height and lung capacity than peers who do not receive ivacaftor.
HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503

FDA Staff Blindsided by Move Allowing More E-Cigs, Nicotine Pouches Onto Market

It's highly unusual for the FDA to draft new policies without input from the staffers
HTTP error: 503HTTP error: 503HTTP error: 503

Upfront Ivonescimab Plus Chemo Bests PD-1 Inhibitor Combo in Advanced NSCLC

HARMONi-6 showed 34% drop in death risk, but trial had an all-Asian population, expert warned

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis

2.

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer

3.

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

4.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

5.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

1.

Colon cancer: Risk factors, warning signs and treatment options 

2.

Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment

3.

Finding Support: Connecting with the Vitiligo Community

4.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

5.

Precision Oncology Using Tumor Evolutionary Trajectory Modeling

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

3.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

5.

Recognizing General Warning Signs of Cancer

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot